Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests

Obstetrics and Gynecology

Volumn 107, Issue 2, 2006, Pages 321-328

  Kulasingam, Shalini L ^a   Myers, Evan R ^a   Lawson, Herschel W ^a   McConnell, K John ^a   Kerlikowske, Karla ^a   Melnikow, Joy ^a   Washington, A Eugene ^a   Sawaya, George F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLPOSCOPY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; SCREENING TEST; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; AGED; COST BENEFIT ANALYSIS; ECONOMICS; MIDDLE AGED; QUALITY ADJUSTED LIFE YEAR; STATISTICS; TIME; VAGINA SMEAR;

ADULT; AGED; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; VAGINAL SMEARS;

EID: 33645452955     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000196500.50044.ce     Document Type: Article

References (21)

1. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol 2003;102:417-27.
2. Screening for cervical cancer: recommendations and rationale. Am Fam Physician 2003;67:1759-66.
3. Noller KL, Bettes B, Zinberg S, Schulkin J. Cervical cytology screening practices among obstetrician-gynecologists. Obstet Gynecol 2003;102:259-65.
4. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 2003;349:1501-9.
5. Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program. Available at: . Retrieved October 9, 2004.
6. Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
7. McCrory DC, Matchar DB, Bastian L, Datta S, Hasselblad V, Hickey J, et al. Evaluation of cervical cytology. Evid Rep Technol Assess (Summ) 1999:1-6.
8. Sawaya GF, Sung HY, Kearney KA, Miller M, Kinney W, Hiatt RA, et al. Advancing age and cervical cancer screening and prognosis. J Am Geriatr Soc 2001;49:1499-504.
9. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000;151:1158-71.
10. Nanda K, McCrory DC, Myers ER, Bastian Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-9.
11. Ratnam S, Franco EL, Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 2000;9:945-51.
12. Arbyn M, Buntinx F, Van Ranst, M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:280-93.
13. ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188:1383-92.
14. Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT, et al. Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 2002;287:2372-81.
15. Kim JJ, Wright TC, Goldie SJ. Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287:2382-90.
16. U.S. Bureau of Labor Statistics. Consumer Price Index, 2003. Available at: . Retrieved on September 9, 2004.
17. Gold MR, Siegel JE, Russel LB, Weinstein MC, editors. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press Inc; 1996.
18. Sadler L, Saftlas A, Wang W, Exeter E, Whittaker J, McCowan L. Treatment for cervical intraepithelial neoplasia and risk of preterm delivery. JAMA 2004;291:2100-6.
19. Samson SL, Bentley JR, Fahey TJ, McKay DJ, Gill GH. The effect of loop electrosurgical excision procedure on future pregnancy outcome. Obstet Gynecol. 2005;105:325-32.
20. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Trends data: nationwide. Available at: . Retrieved October 7, 2004.
21. Leyden WA, Manos MM, Geiger AM Weinmann, S, Mouchawar J, Bischoff K, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005;97:675-83.